Your browser is no longer supported. Please, upgrade your browser.
HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsElite Help
publish chart | save to portfolio | create alert Type: candle | line | advanced | interactive | perf    Timeframe: intraday | daily | weekly | monthly  Settings
ACAD ACADIA Pharmaceuticals Inc. daily Stock Chart
ACAD [NASD]
ACADIA Pharmaceuticals Inc.
Healthcare | Biotechnology | USA
financial highlights | statements
Index- P/E- EPS (ttm)-2.09 Insider Own0.10% Shs Outstand144.43M Perf Week-5.62%
Market Cap3.71B Forward P/E- EPS next Y-1.19 Insider Trans0.00% Shs Float143.75M Perf Month-3.46%
Income-276.20M PEG- EPS next Q-0.46 Inst Own95.00% Short Float9.61% Perf Quarter8.99%
Sales237.90M P/S15.60 EPS this Y-7.70% Inst Trans0.17% Short Ratio13.90 Perf Half Y19.09%
Book/sh2.91 P/B8.83 EPS next Y37.70% ROA-68.10% Target Price32.55 Perf Year46.19%
Cash/sh2.87 P/C8.96 EPS next 5Y34.30% ROE-79.70% 52W Range12.77 - 28.67 Perf YTD58.94%
Dividend- P/FCF- EPS past 5Y-34.30% ROI-51.90% 52W High-10.36% Beta2.85
Dividend %- Quick Ratio6.30 Sales past 5Y187.20% Gross Margin94.50% 52W Low101.25% ATR0.87
Employees465 Current Ratio6.40 Sales Q/Q28.80% Oper. Margin- RSI (14)44.74 Volatility3.19% 3.36%
OptionableYes Debt/Eq0.00 EPS Q/Q-36.10% Profit Margin- Rel Volume1.14 Prev Close26.15
ShortableYes LT Debt/Eq0.00 EarningsAug 07 AMC Payout- Avg Volume993.35K Price25.70
Recom2.30 SMA20-3.03% SMA50-0.52% SMA20011.60% Volume1,137,057 Change-1.72%
Dec-10-18Initiated Canaccord Genuity Hold $23
Sep-21-18Upgrade Piper Jaffray Neutral → Overweight
Aug-09-18Reiterated Stifel Hold $17 → $14
Aug-07-18Initiated Stifel Hold $17
Aug-06-18Downgrade Piper Jaffray Overweight → Neutral
Oct-06-17Resumed Goldman Neutral
Nov-11-16Initiated Goldman Neutral
Nov-08-16Upgrade BofA/Merrill Neutral → Buy
Oct-19-16Resumed ROTH Capital Neutral
Oct-04-16Initiated Leerink Partners Mkt Perform $34
Jun-22-16Downgrade BofA/Merrill Buy → Neutral
May-03-16Downgrade Leerink Partners Outperform → Mkt Perform
Mar-30-16Reiterated Piper Jaffray Overweight $39 → $44
Feb-08-16Initiated BofA/Merrill Buy $40
Jan-22-16Upgrade Piper Jaffray Neutral → Overweight
Aug-27-15Upgrade Piper Jaffray Neutral → Overweight $48
Aug-07-15Reiterated Needham Buy $38 → $49
Aug-07-15Downgrade Piper Jaffray Overweight → Neutral
Apr-16-15Initiated Leerink Partners Outperform $48
Mar-12-15Reiterated Needham Buy $40 → $38
Jul-17-19 09:00AM  ACADIA Pharmaceuticals to Announce Second Quarter 2019 Financial Results on July 31, 2019 Business Wire
Jul-11-19 06:36AM  Does ACADIA Pharmaceuticals Inc.'s (NASDAQ:ACAD) CEO Salary Reflect Performance? Simply Wall St.
Jun-25-19 08:50AM  New National Event Series "Parkinson's IQ + You" Launches to Educate and Empower Parkinson's Disease Patients and Care Partners PR Newswire
Jun-11-19 08:23PM  Is ACADIA Pharmaceuticals Inc. (ACAD) A Good Stock To Buy? Insider Monkey
06:59AM  When Will ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Turn A Profit? Simply Wall St.
Jun-04-19 09:00AM  ACADIA Pharmaceuticals to Present at the Goldman Sachs 40th Annual Global Healthcare Conference Business Wire
May-18-19 11:00AM  ACADIA Pharmaceuticals to Present Phase 2 CLARITY Results for Pimavanserin as an Adjunctive Treatment in Major Depressive Disorder at the 2019 American Psychiatric Association Annual Meeting Business Wire
May-09-19 03:57AM  Edited Transcript of ACAD earnings conference call or presentation 1-May-19 8:30pm GMT Thomson Reuters StreetEvents
May-08-19 03:30PM  Why Acadia Pharmaceuticals Stock Slumped in April Motley Fool
May-07-19 09:00AM  ACADIA Pharmaceuticals to Present at the Bank of America Merrill Lynch Health Care Conference 2019 Business Wire
May-02-19 03:24AM  Acadia Pharmaceuticals (ACAD) Q1 2019 Earnings Call Transcript Motley Fool +7.78%
May-01-19 07:35PM  Acadia Pharmaceuticals (ACAD) Reports Q1 Loss, Tops Revenue Estimates Zacks
06:29PM  Acadia: 1Q Earnings Snapshot Associated Press
04:05PM  ACADIA Pharmaceuticals Reports First Quarter 2019 Financial Results Business Wire
Apr-29-19 09:58PM  Were Hedge Funds Right About Flocking Into ACADIA Pharmaceuticals Inc. (ACAD)? Insider Monkey
Apr-26-19 06:10AM  Analysts point to potential Biogen M&A options after Alzheimer's failure American City Business Journals
Apr-25-19 09:00AM  ACADIA Pharmaceuticals Initiates Phase 3 CLARITY Program with Pimavanserin as Adjunctive Treatment for Major Depressive Disorder Business Wire
Apr-24-19 10:33AM  Analysts Estimate Acadia Pharmaceuticals (ACAD) to Report a Decline in Earnings: What to Look Out for Zacks
Apr-19-19 09:11AM  Should ACADIA Pharmaceuticals (NASDAQ:ACAD) Be Disappointed With Their -30% Profit? Simply Wall St.
Apr-17-19 09:00AM  ACADIA Pharmaceuticals to Announce First Quarter 2019 Financial Results on May 1, 2019 Business Wire -8.58%
Apr-11-19 09:00AM  ACADIA Pharmaceuticals Supports Parkinsons Disease Awareness Month and World Parkinsons Day with Local Educational Initiatives and Community Events Across the Country Business Wire
Apr-02-19 09:00AM  ACADIA Pharmaceuticals to Present at the 18th Annual Needham Healthcare Conference on April 9, 2019 Business Wire
Apr-01-19 09:00AM  ACADIA Pharmaceuticals Announces Promotion of Elena Ridloff, CFA to Executive Vice President, Chief Financial Officer Business Wire
Mar-29-19 07:20AM  Analysis: Positioning to Benefit within American Water Works, TripAdvisor, ACADIA Pharmaceuticals, Dril-Quip, Domtar, and Cara Therapeutics Research Highlights Growth, Revenue, and Consolidated Results GlobeNewswire
Mar-28-19 12:14PM  U.S. Stocks Are Still Stuck Because Uncertainty Is Everywhere Barrons.com
07:54AM  The Daily Biotech Pulse: Blueprint Medicine Expedites Clinical Programs, Eyepoint Offering, Precision Biosciences IPO Benzinga
Mar-27-19 04:10PM  Positive Phase 2 Study Results of Trofinetide in Pediatric Rett Syndrome Published in Neurology, the Medical Journal of the American Academy of Neurology Business Wire
Mar-21-19 06:30AM  HLS Therapeutics Announces Q4 and Year-End 2018 Financial Results CNW Group
Mar-13-19 01:18PM  Is ACADIA Pharmaceuticals Inc.s (NASDAQ:ACAD) Liquidity Good Enough? Simply Wall St.
Mar-05-19 10:40PM  Edited Transcript of ACAD earnings conference call or presentation 26-Feb-19 10:00pm GMT Thomson Reuters StreetEvents
02:36PM  Why Acadia Pharmaceuticals Stock Perked Up in February Motley Fool
Mar-04-19 09:00AM  ACADIA Pharmaceuticals to Present at the Cowen and Company 39th Annual Health Care Conference on March 11, 2019 Business Wire
Feb-27-19 09:30AM  3 Biotech Stocks Boasting Earnings Beats - and Healthy Outlooks TheStreet.com +8.36%
01:05AM  Acadia Pharmaceuticals Inc (ACAD) Q4 2018 Earnings Conference Call Transcript Motley Fool
Feb-26-19 04:05PM  ACADIA Pharmaceuticals Reports Fourth Quarter and Full Year 2018 Financial Results Business Wire
01:28PM  Big Pharma faces the Senate in drug price hearings Yahoo Finance Video
Feb-21-19 09:00AM  ACADIA Pharmaceuticals to Present at the 8th Annual Leerink Partners Global Healthcare Conference on February 28, 2019 Business Wire
Feb-15-19 04:08PM  What's in the Cards for Bausch Health (BHC) Q4 Earnings? Zacks +6.02%
Feb-14-19 12:58PM  5 Drug/Biotech Stocks Set to Beat Estimates in Q4 Earnings Zacks
Feb-13-19 08:15AM  New Research: Key Drivers of Growth for WPX Energy, ACADIA Pharmaceuticals, Lexicon Pharmaceuticals, MobileIron, Arrow Electronics, and Abeona Therapeutics Factors of Influence, Major Initiatives and Sustained Production GlobeNewswire
Feb-12-19 09:00AM  ACADIA Pharmaceuticals to Announce Fourth Quarter and Full Year 2018 Financial Results on February 26, 2019 Business Wire
Feb-11-19 04:51PM  Zoetis (ZTS) to Report Q4 Earnings: What's in the Cards? Zacks
03:58PM  Is a Disappointment in Store for Incyte (INCY) Q4 Earnings? Zacks
Feb-08-19 04:56PM  Tilray (TLRY) to Report Q4 Earnings: What's in the Cards? Zacks
Feb-07-19 04:31PM  Exelixis (EXEL) to Report Q4 Earnings: What's in Store? Zacks
Jan-31-19 07:18PM  Will Gilead (GILD) Q4 Earnings Disappoint on Weak HCV Sales? Zacks
Jan-30-19 10:02AM  Is a Beat in Store for Vertex (VRTX) This Earnings Season? Zacks
Jan-28-19 09:37AM  MacroGenics Up on Lifting of Partial Hold on Cancer Candidate Zacks
08:00AM  Today's Research Reports on Trending Tickers: Amicus Therapeutics and ACADIA Pharmaceuticals ACCESSWIRE
Jan-24-19 06:46AM  Will ACADIA Pharmaceuticals Continue to Surge Higher? Zacks
Jan-21-19 11:48AM  Does ACADIA Pharmaceuticals Inc.s (NASDAQ:ACAD) CEO Pay Compare Well With Peers? Simply Wall St.
Jan-17-19 10:18AM  Amgen's Postmenopausal Osteoporosis Drug Gets FDA Panel Nod Zacks
Jan-11-19 06:08PM  Glancy Prongay & Murray LLP Announces Investigation On Behalf Of ACADIA Pharmaceuticals Inc. Investors (ACAD) GlobeNewswire
Jan-10-19 07:00AM  Today's Research Reports on Trending Tickers: Arena Pharmaceuticals and ACADIA Pharmaceuticals ACCESSWIRE
Jan-08-19 03:38PM  Here's Why ACADIA Pharmaceuticals Dropped 15.2% in December Motley Fool
Dec-20-18 09:00AM  ACADIA Pharmaceuticals to Present at the 37th Annual J.P. Morgan Healthcare Conference on January 9, 2019 Business Wire
Dec-16-18 11:37PM  Is ACADIA Pharmaceuticals Inc. (ACAD) A Good Stock To Buy? Insider Monkey
Dec-13-18 10:46AM  Why ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Could Be Your Next Investment Simply Wall St.
Dec-03-18 08:10AM  Analysis: Positioning to Benefit within Symantec, ACADIA Pharmaceuticals, Novavax, BBX Capital, Paychex, and US Foods Holding Research Highlights Growth, Revenue, and Consolidated Results GlobeNewswire +6.51%
Nov-30-18 04:05PM  ACADIA Pharmaceuticals Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters Option to Purchase Additional Shares Business Wire -5.32%
Nov-28-18 11:01AM  Here's Why Acadia Pharmaceuticals Is Soaring Motley Fool +20.76%
07:00AM  Todays Research Reports on Stocks to Watch: Loxo Oncology and ACADIA Pharmaceuticals ACCESSWIRE
Nov-27-18 09:20PM  ACADIA Pharmaceuticals Prices Public Offering of Common Stock Business Wire -12.64%
03:22PM  Why Acadia Pharmaceuticals Is Plummeting Motley Fool
07:32AM  The Daily Biotech Pulse: Abeona Fires CEO, Loxo Passes FDA Muster, Bristol-Myers Flunks Lung Cancer Trial Benzinga
06:55AM  Today's Research Reports on Trending Tickers: Novavax and ACADIA Pharmaceuticals ACCESSWIRE
Nov-26-18 04:08PM  ACADIA Pharmaceuticals Announces Proposed Public Offering of Common Stock Business Wire +5.13%
Nov-12-18 03:26PM  Edited Transcript of ACAD earnings conference call or presentation 6-Nov-18 10:00pm GMT Thomson Reuters StreetEvents
01:55PM  Analysts Expect Breakeven For ACADIA Pharmaceuticals Inc (NASDAQ:ACAD) Simply Wall St.
Nov-06-18 06:30PM  Acadia Pharmaceuticals (ACAD) Reports Q3 Loss, Tops Revenue Estimates Zacks
05:25PM  Acadia: 3Q Earnings Snapshot Associated Press
04:05PM  ACADIA Pharmaceuticals Reports Third Quarter 2018 Financial Results Business Wire
Nov-01-18 08:00AM  Todays Research Reports on Stocks to Watch: Tonix Pharmaceuticals and ACADIA Pharmaceuticals ACCESSWIRE +14.78%
Oct-31-18 06:30AM  ACADIA Pharmaceuticals Announces Positive Top-line Results from Phase 2 CLARITY Trial of Pimavanserin for Adjunctive Treatment in Patients with Major Depressive Disorder (MDD) Business Wire -7.63%
Oct-30-18 10:33AM  Earnings Preview: Acadia Pharmaceuticals (ACAD) Q3 Earnings Expected to Decline Zacks
08:00AM  The Daily Biotech Pulse: Pfizer And Allergan Earnings, CFO Departures At Acadia And Assertio Benzinga
Oct-29-18 04:35PM  ACADIA Pharmaceuticals Announces Executive Leadership Change Business Wire
Oct-26-18 08:00AM  Today's Research Reports on Trending Tickers: ACADIA Pharmaceuticals and Array BioPharma ACCESSWIRE
Oct-24-18 08:50AM  Market Trends Toward New Normal in UROGEN PHARMA, Cimarex Energy, Boingo Wireless, TransCanada, EXTRACTION O&G, and ACADIA Pharmaceuticals Emerging Consolidated Expectations, Analyst Ratings GlobeNewswire -12.55%
Oct-23-18 09:00AM  ACADIA Pharmaceuticals to Announce Third Quarter 2018 Financial Results on November 6, 2018 Business Wire
Oct-22-18 06:00AM  3 Biotech Stocks Poised to Rise by 15% or More Investopedia
Oct-12-18 08:00AM  Today's Research Reports on Trending Tickers: Oragenics and ACADIA Pharmaceuticals ACCESSWIRE
Oct-10-18 01:30PM  Here's Why ACADIA Pharmaceuticals Jumped 46% in September Motley Fool
10:35AM  Biotech Gearing Up for a Pullback? Investopedia
Sep-27-18 06:00AM  3 Biotechs Poised for 10% Gains Investopedia
Sep-26-18 03:07PM  ACADIA Pharmaceuticals Inc (NASDAQ:ACAD): Financial Strength Analysis Simply Wall St.
09:00AM  ACADIA Pharmaceuticals Announces Executive Appointments to Lead Medical Affairs and Science Business Wire
08:26AM  Biotech Stock Roundup: ALXN Soliris Successful, Respite For Sarepta, AMRN Soars Zacks
08:00AM  Today's Research Reports on Trending Tickers: ACADIA Pharmaceuticals and Array BioPharma ACCESSWIRE
Sep-25-18 09:00AM  ACADIA Pharmaceuticals to Present at the 2018 Cantor Global Healthcare Conference on October 2, 2018 Business Wire +7.86%
Sep-24-18 04:27PM  8 Stocks Poised to Change Direction TheStreet.com
08:00AM  Today's Research Reports on Trending Tickers: Geron and ACADIA Pharmaceuticals ACCESSWIRE
Sep-22-18 07:17AM  3 Biotech Stocks That Soared This Week: Are They Buys? Motley Fool
Sep-21-18 06:12PM  FDA Confirms Positive Safety Profile of Acadia's Nuplazid Zacks +5.55%
03:53PM  Bulls bet on this pharma name. Plus, the trade on Zions CNBC Videos
11:21AM  Acadia's FDA Boost Is Just The Beginning, Piper Jaffray Says In Upgrade Benzinga
10:00AM  FINAL DEADLINE ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against ACADIA Pharmaceuticals Inc. (ACAD) & Lead Plaintiff Deadline - September 17, 2018 GlobeNewswire
08:00AM  Today's Research Reports on Trending Tickers: ACADIA Pharmaceuticals and BioLineRx ACCESSWIRE
Sep-20-18 05:15PM  FDA Issues Statement Reaffirming the Positive Benefit-Risk Profile of NUPLAZID® (pimavanserin) for Patients with Hallucinations and Delusions Associated with Parkinsons Disease Psychosis Business Wire +26.56%
05:01PM  Here's Why Acadia Pharmaceuticals Inc. Spiked Over 26% Today Motley Fool
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It is also developing pimavanserin as a treatment for dementia-related psychosis and as an adjunctive treatment for schizophrenia that are in Phase III clinical trials; and pimavanserin as an adjunctive treatment for major depressive disorder. ACADIA Pharmaceuticals Inc. was founded in 1993 and is headquartered in San Diego, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Brege LauraDirectorJan 09Option Exercise2.1610,00021,60010,000Jan 11 04:32 PM
Brege LauraDirectorJan 09Sale20.0010,000200,0410Jan 11 04:32 PM
BAKER BROS. ADVISORS LPDirectorNov 30Buy17.0011,764,705199,999,98535,976,940Dec 04 05:00 PM
BAKER BROS. ADVISORS LPDirectorSep 20Buy18.701,210,77622,646,98924,798,117Sep 24 08:32 AM
open in yahoo | open in reuters | open in google